14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Predictions

$1.23
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

CTRV Predictions History

6 years ago
JS predicted that CTRV for 2017-08-30 is going $0.529 (-99.81%)

6 years ago
JuanC Villegas predicted that CTRV for 2017-08-30 is going $0.521 (-99.82%)

6 years ago
MILAN.PATEL.39 predicted that CTRV for 2017-08-30 is going $0.541 (-99.82%)

Rank:

6 years ago
flash predicted that CTRV for 2017-07-06 is going $0.189 (-99.94%)

Rank:

6 years ago
Kei predicted that CTRV for 2017-06-09 is going $0.640 (-99.82%)

Rank:

6 years ago
JS predicted that CTRV for 2017-05-15 is going $0.733 (-99.81%)

6 years ago
Jay predicted that CTRV for 2017-05-15 is going $0.82 (-99.79%)

Rank:

6 years ago
JS predicted that CTRV for 2017-05-11 is going $0.709 (-99.81%)

6 years ago
JuanC Villegas predicted that CTRV for 2017-05-11 is going $0.616 (-99.83%)

7 years ago
JS predicted that CTRV for 2017-05-02 is going $0.84 (-99.82%)

Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT